Advances of Systemic Treatment for Adult Soft-Tissue Sarcoma

Wenshuai Liu; Quan Jiang; Yuhong Zhou


Chin Clin Oncol. 2018;7(4) 

In This Article


Due to the advances of systemic treatment for STS in recent years, the outcome of STS has been greatly improved. As the molecular pathogenic basis of various histologic subtypes of STS has been revealed, the development of other promising molecular targeted therapy and immunotherapy will move the therapeutic modality from the all-fits-one approach for a more personalized therapeutic algorithm in the near future.